← 返回搜尋
Congenital bile acid synthesis defect type 2
ORPHA:79303 · Disease · Disorder
HPO 表現型(共 27 項)
Very frequent (99-80%)(3)
- Abnormal circulating enzyme concentration or activityHP:0012379
- Giant cell hepatitisHP:0200084
- HyperbilirubinemiaHP:0002904
Frequent (79-30%)(21)
- Abnormal serum bile acid concentrationHP:0030984
- Abnormality of the coagulation cascadeHP:0003256
- CholestasisHP:0001396
- Conjugated hyperbilirubinemiaHP:0002908
- Dark urineHP:0040319
- Decreased circulating vitamin E concentrationHP:0100513
- Elevated circulating alkaline phosphatase concentrationHP:0003155
- Elevated circulating hepatic transaminase concentrationHP:0002910
- Extramedullary hematopoiesisHP:0001978
- Failure to thriveHP:0001508
- Fat malabsorptionHP:0002630
- Hepatic failureHP:0001399
- Hepatic steatosisHP:0001397
- HepatomegalyHP:0002240
- Increased circulating lactate dehydrogenase concentrationHP:0025435
- JaundiceHP:0000952
- Postnatal growth retardationHP:0008897
- Prolonged neonatal jaundiceHP:0006579
- Prolonged partial thromboplastin timeHP:0003645
- Prolonged prothrombin timeHP:0008151
- SteatorrheaHP:0002570
Occasional (29-5%)(3)
- Abnormal intrahepatic bile duct morphologyHP:0011040
- Renal cystHP:0000107
- RicketsHP:0002748